Table 3 Classification of patients according to each classifier (RlapsRisk BC, Clinical score, and RR Combined)
From: Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides
CANTO validation cohort (N = 1169) | |||
|---|---|---|---|
RlapsRisk BC classifier | Clinical score classifier | RR Combined classifier | |
Number at low riska | 893 | 879 | 910 |
Number at high riskb | 276 | 290 | 259 |
% of patients with MFS events in the low-risk group | 1.56% | 1.59% | 1.32% |
% of patients with MFS events in the high-risk group | 8.69% | 8.28% | 10.04% |
Kaplan–Meier’s hazard ratio | 5.83 | 5.51 | 8.01 |
95% CI | (3.02–11.28) | (2.85–10.66) | (4.04–15.88) |
Log-rank p value | <0.005 | <0.005 | <0.005 |
